The DOI matches its Crossref record; 103 of the 103 references it cites were found in a registry or an index.
The Concept of Depression as a Dysfunction of the Immune System
Open accessAbstract
Chronic stress, by initiating changes in the hypothalamic-pituitary-adrenal axis and the immune system, acts as a trigger for anxiety and depression. Both experimental and clinical evidence shows that a rise in the concentrations of proinflammatory cytokines and glucocorticoids, as occurs in chronically stressful situations and in depression, contribute to the behavioural changes associated with depression.A defect in serotonergic function is associated with hypercortisolaemia and the increase in proinflammatory cytokines that accompany depression. Glucocorticoids and proinflammatory cytokines enhance the conversion of tryptophan to kynurenine. In addition to the resulting decrease in the synthesis of brain serotonin, this leads to the formation of neurotoxins such as the glutamate agonist quinolinic acid and contributes to the increase in apoptosis of astrocytes, oligodendroglia and neurons.The importance of the inflammation hypothesis of depression lies in raising the possibility that psychotropic drugs that have a central anti-inflammatory action might provide a new generation of antidepressants.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Molecular Mechanisms of Depression: Perspectives on New Treatment Strategies
Lang, U. E., & Borgwardt, S. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000350094 · Cited by 8,475
From inflammation to sickness and depression: when the immune system subjugates the brain
Dantzer, R., O'Connor, J. C., Freund, G. G., Johnson, R. W., & Kelley, K. W. (2008) · Nature Reviews Neuroscience · doi:10.1038/nrn2297 · Cited by 7,395
A Meta-Analysis of Cytokines in Major Depression
Dowlati, Y., Herrmann, N., Swardfager, W., Liu, H., Sham, L., Reim, E. K., & Lanctôt, K. L. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.09.033 · Cited by 4,729 · cited 1×
“Recently a meta-analysis of 9 cytokines in major depression in which 24 studies were assessed[8] concluded that only the basal levels of IL-6 and TNF were significantly raised.”
Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study
Murray, C. J., & Lopez, A. D. (1997) · The Lancet · doi:10.1016/s0140-6736(96)07495-8 · Cited by 4,492
Depression, chronic diseases, and decrements in health: results from the World Health Surveys
Moussavi, S., Chatterji, S., Verdes, E., Tandon, A., Patel, V., & Ustun, B. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61415-9 · Cited by 4,070
Inflammation and Its Discontents: The Role of Cytokines in the Pathophysiology of Major Depression
Miller, A. H., Maletic, V., & Raison, C. L. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.11.029 · Cited by 3,848
Cytokines sing the blues: inflammation and the pathogenesis of depression
Raison, C. L., Capuron, L., & Miller, A. H. (2006) · Trends in Immunology · doi:10.1016/j.it.2005.11.006 · Cited by 3,009
Extrasynaptic NMDARs oppose synaptic NMDARs by triggering CREB shut-off and cell death pathways
Hardingham, G. E., Fukunaga, Y., & Bading, H. (2002) · Nature Neuroscience · doi:10.1038/nn835 · Cited by 1,686
Glial reduction in the subgenual prefrontal cortex in mood disorders
Öngür, D., Drevets, W. C., & Price, J. L. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.22.13290 · Cited by 1,525 · cited 1×
“The net result of these changes is a loss of astrocytes and oligodendroglia, and neuronal apoptosis particularly in the subgenual prefrontal cortex, the amygdala and the hippocampus, brain regions that are thought to be crucially involved in the genesis of the symptoms of depression.[48].”
Rajkowska, G., Miguel-Hidalgo, J. J., Wei, J., Dilley, G., Pittman, S. D., Meltzer, H. Y., Overholser, J. C., Roth, B. L., & Stockmeier, C. A. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00041-4 · Cited by 1,477 · cited 1×
“It is known that there is a shrinkage of the hippocampus in patients with major depression [58] and a decrease in the number of astrocytes and a neuronal loss in the prefrontal cortex [59] and in the striatum.”
Sheline, Y. I., Sanghavi, M., Mintun, M. A., & Gado, M. H. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-12-05034.1999 · Cited by 1,382 · cited 1×
“The structural changes observed in the brain of patients with chronic depression lends support to the neurodegenerative hypothesis of depression [57].”
Cytokine-Associated Emotional and Cognitive Disturbances in Humans
Reichenberg, A., Yirmiya, R., Schuld, A., Kraus, T., Haack, M., Morag, A., & Pollmächer, T. (2001) · Archives of General Psychiatry · doi:10.1001/archpsyc.58.5.445 · Cited by 1,365
Glucocorticoid receptors in major depression: relevance to pathophysiology and treatment
Pariante, C. M., & Miller, A. H. (2001) · Biological Psychiatry · doi:10.1016/s0006-3223(00)01088-x · Cited by 1,147 · cited 1×
“In addition to the modulation of neurotransmitter function, proinflammatory cytokines contribute to the major symptoms of depression by activating the HPA axis by increasing the release of CRF, thereby contributing to hypercortisolaemia, a feature of major depression [18,19,20].”
A mechanism converting psychosocial stress into mononuclear cell activation
Bierhaus, A., Wolf, J., Andrassy, M., Rohleder, N., Humpert, P. M., Petrov, D., Ferstl, R., von Eynatten, M., Wendt, T., Rudofsky, G., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0438019100 · Cited by 927
Maes, M., Yirmyia, R., Noraberg, J., Brene, S., Hibbeln, J., Perini, G., Kubera, M., Bob, P., Lerer, B., & Maj, M. (2009) · Metabolic Brain Disease · doi:10.1007/s11011-008-9118-1 · Cited by 894
Perkins, M. N., & Stone, T. W. (1982) · Brain Research · doi:10.1016/0006-8993(82)91048-4 · Cited by 849
Pace, T. W. W., Mletzko, T. C., Alagbe, O., Musselman, D. L., Nemeroff, C. B., Miller, A. H., & Heim, C. M. (2006) · American Journal of Psychiatry · doi:10.1176/ajp.2006.163.9.1630 · Cited by 810
Subtype-Specific Alterations of γ-Aminobutyric Acid and Glutamatein Patients With Major Depression
Sanacora, G., Gueorguieva, R., Epperson, C. N., Wu, Y.-T., Appel, M., Rothman, D. L., Krystal, J. H., & Mason, G. F. (2004) · Archives of General Psychiatry · doi:10.1001/archpsyc.61.7.705 · Cited by 796
Müller, N., Schwarz, M. J., Dehning, S., Douhe, A., Cerovecki, A., Goldstein-Müller, B., Spellmann, I., Hetzel, G., Maino, K., Kleindienst, N., et al. (2006) · Molecular Psychiatry · doi:10.1038/sj.mp.4001805 · Cited by 794
Endogenous kynurenines as targets for drug discovery and development
Stone, T. W., & Darlington, L. G. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd870 · Cited by 768
Harrison, N. A., Brydon, L., Walker, C., Gray, M. A., Steptoe, A., & Critchley, H. D. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.03.015 · Cited by 756
Cytokine Production and Treatment Response in Major Depressive Disorder
Lanquillon, S. (2000) · Neuropsychopharmacology · doi:10.1016/s0893-133x(99)00134-7 · Cited by 735
Maes, M., Bosmans, E., De Jongh, R., Kenis, G., Vandoolaeghe, E., & Neels, H. (1997) · Cytokine · doi:10.1006/cyto.1997.0238 · Cited by 728
Hostile Marital Interactions, Proinflammatory Cytokine Production, and Wound Healing
Kiecolt-Glaser, J. K., Loving, T. J., Stowell, J. R., Malarkey, W. B., Lemeshow, S., Dickinson, S. L., & Glaser, R. (2005) · Archives of General Psychiatry · doi:10.1001/archpsyc.62.12.1377 · Cited by 715 · cited 1×
“However, chronic stress, as experienced by caregivers or individual subject to marital discord but who are not suffering from depression also show an increase in plasma C-reactive protein, IL-6 and other inflammatory mediators [24,25].”
Brain-immune communication pathways
Quan, N., & Banks, W. A. (2007) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2007.05.005 · Cited by 626 · cited 1×
“It was also apparent that about 45% of patients being therapeutically treated with the proinflammatory cytokine interferon-alpha (IFN) developed major symptoms of depression that terminate when the cytokines was withdrawn [7].”
Maes, M., Meltzer, H. Y., Bosmans, E., Bergmans, R., Vandoolaeghe, E., Ranjan, R., & Desnyder, R. (1995) · Journal of Affective Disorders · doi:10.1016/0165-0327(95)00028-l · Cited by 622
The cholinergic anti-inflammatory pathway
Pavlov, V. A., & Tracey, K. J. (2005) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2005.03.015 · Cited by 622
Pace, T. W. W., Hu, F., & Miller, A. H. (2007) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2006.08.009 · Cited by 621
Gliogenesis and Glial Pathology in Depression
Rajkowska, G., & Miguel-Hidalgo, J. (2007) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/187152707780619326 · Cited by 610
Frank, M. G., Baratta, M. V., Sprunger, D. B., Watkins, L. R., & Maier, S. F. (2007) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2006.03.005 · Cited by 578
Zhu, C.-B., Blakely, R. D., & Hewlett, W. A. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301029 · Cited by 549
Kynurenine pathway metabolism in human astrocytes: a paradox for neuronal protection
Guillemin, G. J., Kerr, S. J., Smythe, G. A., Smith, D. G., Kapoor, V., Armati, P. J., Croitoru, J., & Brew, B. J. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00498.x · Cited by 538
Kynurenine pathway in major depression: Evidence of impaired neuroprotection
Myint, A.-M., Kim, Y. K., Verkerk, R., Scharpé, S., Steinbusch, H., & Leonard, B. (2007) · Journal of Affective Disorders · doi:10.1016/j.jad.2006.07.013 · Cited by 527
O'Connor, J. C., André, C., Wang, Y., Lawson, M. A., Szegedi, S. S., Lestage, J., Castanon, N., Kelley, K. W., & Dantzer, R. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.5032-08.2009 · Cited by 502
A dual role for interleukin-1 in hippocampal-dependent memory processes
Goshen, I., Kreisel, T., Ounallah-Saad, H., Renbaum, P., Zalzstein, Y., Ben-Hur, T., Levy-Lahad, E., & Yirmiya, R. (2007) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2007.09.004 · Cited by 500
Lucassen, P. J., Meerlo, P., Naylor, A. S., van Dam, A. M., Dayer, A. G., Fuchs, E., Oomen, C. A., & Czéh, B. (2010) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2009.08.003 · Cited by 449
Wichers, M. C., Koek, G. H., Robaeys, G., Verkerk, R., Scharpé, S., & Maes, M. (2005) · Molecular Psychiatry · doi:10.1038/sj.mp.4001600 · Cited by 445
Role of Serotonin in the Immune System and in Neuroimmune Interactions
Mössner, R., & Lesch, K.-P. (1998) · Brain, Behavior, and Immunity · doi:10.1006/brbi.1998.0532 · Cited by 434
Choi, S.-H., Aid, S., & Bosetti, F. (2009) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2009.01.002 · Cited by 402
Indicators of immune activation in major depression
Sluzewska, A., Rybakowski, J., Bosmans, E., Sobieska, M., Berghmans, R., Maes, M., & Wiktorowicz, K. (1996) · Psychiatry Research · doi:10.1016/s0165-1781(96)02783-7 · Cited by 384
Neuroinflammation and regulation of glial glutamate uptake in neurological disorders
Tilleux, S., & Hermans, E. (2007) · Journal of Neuroscience Research · doi:10.1002/jnr.21325 · Cited by 381
Cytokine–serotonin interaction through IDO: a neurodegeneration hypothesis of depression
Myint, A. M., & Kim, Y. K. (2003) · Medical Hypotheses · doi:10.1016/s0306-9877(03)00207-x · Cited by 374
Effects of antidepressants on the production of cytokines
Kenis, G., & Maes, M. (2002) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145702003164 · Cited by 370
Raison, C. L., Borisov, A. S., Majer, M., Drake, D. F., Pagnoni, G., Woolwine, B. J., Vogt, G. J., Massung, B., & Miller, A. H. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.08.010 · Cited by 367
Inflammation, Depression and Dementia: Are they Connected?
Leonard, B. E. (2007) · Neurochemical Research · doi:10.1007/s11064-007-9385-y · Cited by 342
Self-citationANISMAN, H., MERALI, Z., & HAYLEY, S. (2008) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2008.01.004 · Cited by 337
McDade, T. W., Hawkley, L. C., & Cacioppo, J. T. (2006) · Psychosomatic Medicine · doi:10.1097/01.psy.0000221371.43607.64 · Cited by 326 · cited 2×
“However, chronic stress, as experienced by caregivers or individual subject to marital discord but who are not suffering from depression also show an increase in plasma C-reactive protein, IL-6 and other inflammatory mediators [24,25].”
Morrow, G. R., Hickok, J. T., Roscoe, J. A., Raubertas, R. F., Andrews, P. L. R., Flynn, P. J., Hynes, H. E., Banerjee, T. K., Kirshner, J. J., & King, D. K. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.04.070 · Cited by 324 · cited 1×
“However, there is abundant clinical evidence that the available antidepressants, though largely effective in attenuating the depressed mood state and associated symptoms of anxiety, are far less effective in treating the memory and cognitive dysfunction (fatigue, psychomotor retardation) that commonly affect middle ag…”
Cytokines as modulators of the hypothalamus-pituitary-adrenal axis
Besedovsky, H. O., Del Rey, A., Klusman, I., Furukawa, H., Monge Arditi, G., & Kabiersch, A. (1991) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/0960-0760(91)90284-c · Cited by 314
Wong, M.-L., Dong, C., Maestre-Mesa, J., & Licinio, J. (2008) · Molecular Psychiatry · doi:10.1038/mp.2008.59 · Cited by 295
O'Connor, J. C., Lawson, M. A., André, C., Briley, E. M., Szegedi, S. S., Lestage, J., Castanon, N., Herkenham, M., Dantzer, R., & Kelley, K. W. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0802722 · Cited by 295
Serotonin receptor binding in a colony model of chronic social stress
McKittrick, C. R., Caroline Blanchard, D., Blanchard, R. J., McEwen, B. S., & Sakai, R. R. (1995) · Biological Psychiatry · doi:10.1016/0006-3223(94)00152-s · Cited by 281
Morón, J. A., Zakharova, I., Ferrer, J. V., Merrill, G. A., Hope, B., Lafer, E. M., Lin, Z. C., Wang, J. B., Javitch, J. A., Galli, A., et al. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-24-08480.2003 · Cited by 262 · cited 3×
“Cytokines, and their signalling pathways, have been shown to enhance the re-uptake of monoamine neurotransmitters and thereby reduce their functionally important inter-synaptic concentrations in the brain [16,17].”
Cyclooxygenase-2 Contributes to Functional Hyperemia in Whisker-Barrel Cortex
Niwa, K., Araki, E., Morham, S. G., Ross, M. E., & Iadecola, C. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-02-00763.2000 · Cited by 261
Barrientos, R. M., Sprunger, D. B., Campeau, S., Higgins, E. A., Watkins, L. R., Rudy, J. W., & Maier, S. F. (2003) · Neuroscience · doi:10.1016/s0306-4522(03)00564-5 · Cited by 251
Molecular mechanisms of microglial activation
Zielasek, J., & Hartung, H.-P. (1996) · Advances in Neuroimmunology · doi:10.1016/0960-5428(96)00017-4 · Cited by 244
Repeated stress increases catalytic TrkB mRNA in rat hippocampus
Nibuya, M., Takahashi, M., Russell, D. S., & Duman, R. S. (1999) · Neuroscience Letters · doi:10.1016/s0304-3940(99)00335-3 · Cited by 236
Mendlewicz, J., Kriwin, P., Oswald, P., Souery, D., Alboni, S., & Brunello, N. (2006) · International Clinical Psychopharmacology · doi:10.1097/00004850-200607000-00005 · Cited by 229
Glutamate uptake by oligodendrocytes: Implications for excitotoxicity in multiple sclerosis
Pitt, D., Nagelmeier, I. E., Wilson, H. C., & Raine, C. S. (2003) · Neurology · doi:10.1212/01.wnl.0000090564.88719.37 · Cited by 222
Bernardino, L., Agasse, F., Silva, B., Ferreira, R., Grade, S., & Malva, J. O. (2008) · Stem Cells · doi:10.1634/stemcells.2007-0914 · Cited by 220
Depression, immunocompetence, and prostaglandins of the E series
Calabrese, J. R., Skwerer, R. G., Barna, B., Gulledge, A. D., Valenzuela, R., Butkus, A., Subichin, S., & Krupp, N. E. (1986) · Psychiatry Research · doi:10.1016/0165-1781(86)90040-5 · Cited by 205
Meijer, O. C., & de Kloet, E. R. (1998) · Critical Reviews™ in Neurobiology · doi:10.1615/critrevneurobiol.v12.i1-2.10 · Cited by 203
(1991) · American Journal of Psychiatry · doi:10.1176/ajp.148.8.1009 · Cited by 203
Cyclooxygenase-2 in synaptic signaling
Yang, H., & Chen, C. (2008) · Current Pharmaceutical Design · doi:10.2174/138161208784480144 · Cited by 195
Inhibition of glial inflammatory activation and neurotoxicity by tricyclic antidepressants
Hwang, J., Zheng, L. T., Ock, J., Lee, M. G., Kim, S.-H., Lee, H.-W., Lee, W.-H., Park, H.-C., & Suk, K. (2008) · Neuropharmacology · doi:10.1016/j.neuropharm.2008.06.045 · Cited by 181
Future therapeutic targets in mood disorders: the glucocorticoid receptor
McQuade, R., & Young, A. H. (2000) · The British Journal of Psychiatry · doi:10.1192/bjp.177.5.390 · Cited by 177
Vieira, P. L., Kaliński, P., Wierenga, E. A., Kapsenberg, M. L., & de Jong, E. C. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.10.5245 · Cited by 176
Marchetti, B., & Abbracchio, M. P. (2005) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2005.08.007 · Cited by 175
Modulation of astrocytic metabolic phenotype by proinflammatory cytokines
Gavillet, M., Allaman, I., & Magistretti, P. J. (2008) · Glia · doi:10.1002/glia.20671 · Cited by 171
Infliximab Improves Quality of Life in Patients with Crohn's Disease
Lichtenstein, G. R., Bala, M., Han, C., DeWoody, K., & Schaible, T. (2002) · Inflammatory Bowel Diseases · doi:10.1097/00054725-200207000-00001 · Cited by 165
Kitagami, T., Yamada, K., Miura, H., Hashimoto, R., Nabeshima, T., & Ohta, T. (2003) · Brain Research · doi:10.1016/s0006-8993(03)02776-8 · Cited by 163
Interleukin-4 inhibits indoleamine 2,3-dioxygenase expression in human monocytes.
Musso, T., Gusella, G., Brooks, A., Longo, D., & Varesio, L. (1994) · Blood · doi:10.1182/blood.v83.5.1408.1408 · Cited by 158
Buntinx, M., Moreels, M., Vandenabeele, F., Lambrichts, I., Raus, J., Steels, P., Stinissen, P., & Ameloot, M. M. (2004) · Journal of Neuroscience Research · doi:10.1002/jnr.20118 · Cited by 153
Lymphocytes transport serotonin and dopamine: agony or ecstasy?
Gordon, J., & Barnes, N. M. (2003) · Trends in Immunology · doi:10.1016/s1471-4906(03)00176-5 · Cited by 152
CSF Prostaglandin Levels in Depressed and Schizophrenic Patients
Linnoila, M. (1983) · Archives of General Psychiatry · doi:10.1001/archpsyc.1983.01790040059008 · Cited by 150
O'Sullivan, J. B., Ryan, K. M., Curtin, N. M., Harkin, A., & Connor, T. J. (2009) · The International Journal of Neuropsychopharmacology · doi:10.1017/s146114570800967x · Cited by 146
Frasure‐Smith, N., Lespérance, F., Irwin, M. R., Sauvé, C., Lespérance, J., & Théroux, P. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.09.029 · Cited by 145
Shen, Y., Connor, T. J., Nolan, Y. M., Kelly, J. P., & Leonard, B. E. (1999) · Life Sciences · doi:10.1016/s0024-3205(99)00430-0 · Cited by 133
Mößner, R. (1998) · Neurochemistry International · doi:10.1016/s0197-0186(98)00026-6 · Cited by 130
Dexamethasone for the treatment of depression: a randomized, placebo- controlled, double-blind trial
Arana, G. W., Santos, A. B., Laraia, M. T., McLeod-Bryant, S., Beale, M. D., Rames, L. J., Roberts, J. M., Dias, J. K., & Molloy, M. A. (1995) · American Journal of Psychiatry · doi:10.1176/ajp.152.2.265 · Cited by 125
Taler, M., Gil‐Ad, I., Lomnitski, L., Korov, I., Baharav, E., Bar, M., Zolokov, A., & Weizman, A. (2007) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2007.03.010 · Cited by 121
Myint, A.-M., Steinbusch, H. W. M., Goeghegan, L., Luchtman, D. W., Kim, Y. K., & Leonard, B. E. (2007) · NeuroImmunoModulation · doi:10.1159/000107420 · Cited by 113
Mathias, S. D., Colwell, H. H., Miller, D. P., Moreland, L. W., Buatti, M. C., & Wanke, L. A. (2000) · Clinical Therapeutics · doi:10.1016/s0149-2918(00)87984-9 · Cited by 112
Regulation of 5‐HT receptors by corticosteroids: where do we stand?
Chaouloff, F. (1995) · Fundamental and Clinical Pharmacology · doi:10.1111/j.1472-8206.1995.tb00289.x · Cited by 112
Interleukin-6 response to exercise and high-altitude exposure: influence of α-adrenergic blockade
Mazzeo, R. S., DoNOVAN, D. K. O. '., Fleshner, M., Butterfield, G. E., Zamudio, S., Wolfel, E. E., & MOORE, L. G. (2001) · Journal of Applied Physiology · doi:10.1152/jappl.2001.91.5.2143 · Cited by 110
Liu, Q., Li, B., Zhu, H., Wang, Y., Yu, J. M., & Wu, G.-C. (2009) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2009.06.010 · Cited by 86
Grant, R., & Kapoor, V. (1998) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1998.70041759.x · Cited by 85
Central mediation of the effects of interleukin-1 on social exploration and body weight in mice
Bluthé, R.-M., Dantzer, R., & Kelley, K. W. (1997) · Psychoneuroendocrinology · doi:10.1016/s0306-4530(96)00042-x · Cited by 84
Godbout, J. P., Berg, B. M., Krzyszton, C. P., & Johnson, R. W. (2005) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2005.08.003 · Cited by 84
Si, Q., Cosenza, M., Kim, M.-O., Zhao, M., Brownlee, M., Goldstein, H., & Lee, S. C. (2004) · Journal of NeuroVirology · doi:10.1080/13550280490499533 · Cited by 73
Choi, S., Langenbach, R. I., & Bosetti, F. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.03926.x · Cited by 67
Treatment of inflammatory diseases by selective eicosanoid inhibition: a double-edged sword?
Yedgar, S., Krimsky, M., Cohen, Y., & Flower, R. J. (2007) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2007.07.005 · Cited by 65
Song, C. (2002) · Brain Behavior and Immunity · doi:10.1016/s0889-1591(02)00012-0 · Cited by 61
Stress, Depression, and The Role of Cytokines
Leonard, B. E., & Song, C. (1999) · Advances in experimental medicine and biology · doi:10.1007/978-0-585-37970-8_14 · Cited by 60
Calogero, A. E., Bagdy, G., Moncada, M. L., & D’Agata, R. (1993) · Journal of Endocrinology · doi:10.1677/joe.0.1360381 · Cited by 60
Åberg‐Wistedt, A., Hasselmark, L., Stain‐Malmgren, R., Apéria, B., Kjellman, B., & Mathé, A. A. (1998) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1998.tb10017.x · Cited by 56
Is thymus redundant after adulthood?
Shanker, A. (2004) · Immunology Letters · doi:10.1016/j.imlet.2003.12.012 · Cited by 51
Neumaier, J. F., Petty, F., Kramer, G. L., Szot, P., & Hamblin, M. W. (1997) · Biological Psychiatry · doi:10.1016/s0006-3223(96)00114-x · Cited by 51
Taler, M., Bar, M., Korob, I., Lomnitski, L., Baharav, E., Grunbaum-Novak, N., Weizman, A., & Gil‐Ad, I. (2008) · International Immunopharmacology · doi:10.1016/j.intimp.2007.12.003 · Cited by 42
Davis, S., Stanford, S. C., & Heal, D. J. (1995) · Psychopharmacology · doi:10.1007/bf02245954 · Cited by 41
5-Hydroxytryptamine receptor function in humans is reduced by acute administration of hydrocortisone
Porter, R. J., McAllister-Williams, H., Lunn, B. S., & Young, A. H. (1998) · Psychopharmacology · doi:10.1007/s002130050711 · Cited by 32
Immune-endocrine host response to endotoxin in major depression
Vedder, H., Schreiber, W., Schuld, A., Kainz, M., Lauer, C. J., Krieg, J.-C., Holsboer, F., & Pollmächer, T. (2007) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2006.07.014 · Cited by 27
Pitychoutis, P. M., Griva, E., Ioannou, K., Tsitsilonis, O., & Papadopoulou‐Daifoti, Z. (2009) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145709990502 · Cited by 23
Cited by
Slavich, G. M., & Irwin, M. R. (2014) · Psychological Bulletin · doi:10.1037/a0035302 · Cited by 2,206
Burnout–Depression Overlap: A Review
Bianchi, R., Schonfeld, I. S., & Laurent, E. (2015) · Clinical Psychology Review · doi:10.1016/j.cpr.2015.01.004 · Cited by 868
Neuroinflammation and psychiatric illness
Najjar, S., Pearlman, D. M., Alper, K., Najjar, A., & Devinsky, O. (2013) · Journal of Neuroinflammation · doi:10.1186/1742-2094-10-43 · Cited by 733
“Limited in vitro evidence suggests that inflammation/ proinflammatory cytokines can increase CNS glutamate levels [188] in a feed-forward cycle through several potential mechanisms: 1) proinflammatory cytokines can inhibit [15,17,168] and reverse [45,137] astroglial EAAT-mediated glutamate reuptake function; 2) proinf…”
Depression in HIV Infected Patients: a Review
Nanni, M. G., Caruso, R., Mitchell, A. J., Meggiolaro, E., & Grassi, L. (2015) · Current Psychiatry Reports · doi:10.1007/s11920-014-0530-4 · Cited by 511
Mikulska, J., Juszczyk, G., Gawrońska-Grzywacz, M., & Herbet, M. (2021) · Brain Sciences · doi:10.3390/brainsci11101298 · Cited by 450
Metadata
- Authors
- E. Leonard, B.
- Venue
- Current Immunology Reviews
- Publisher
- Bentham Science Publishers Ltd.
- Published
- 2010-08-01
- Volume
- 6
- Issue
- 3
- Pages
- 205-212
- ISSN
- 1573-3955 (ISSN-L)
- OpenAlex
- W2073715243
- Cited by
- 276
- References
- 103
- FWCI
- 3.96
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.